Literature DB >> 14963268

Patent foramen ovale and recurrent stroke: closure is the best option: no.

David C Tong1, Kyra J Becker.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14963268     DOI： 10.1161/01.STR.0000117964.10781.BA

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  9 in total

Review 1.  Is patent foramen ovale a modifiable risk factor for stroke recurrence?

Authors:  David M Kent; David E Thaler
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

2.  Patent foramen ovale and stroke: prognosis and treatment in young adults.

Authors:  Steven C Cramer
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

Review 3.  Antithrombotic therapy for stroke in young adults.

Authors:  Jeremy R Payne; Bruce Coull
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

4.  Patent foramen ovale: the never-ending story.

Authors:  Gérald Devuyst; Julien Bogousslavsky
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-07

5.  Heart-brain signaling in patent foramen ovale-related stroke: differential plasma proteomic expression patterns revealed with a 2-pass liquid chromatography-tandem mass spectrometry discovery workflow.

Authors:  Mary F Lopez; David A Sarracino; Maryann Vogelsang; Jennifer N Sutton; Michael Athanas; Bryan Krastins; Alejandra Garces; Amol Prakash; Scott Peterman; Zareh Demirjian; Ignacio Inglessis-Azuaje; Kathleen Feeney; Mikaela Elia; David McMullin; G William Dec; Igor Palacios; Eng H Lo; Ferdinand Buonanno; MingMing Ning
Journal:  J Investig Med       Date:  2012-12       Impact factor: 2.895

6.  Interactions between cardiovascular and cerebrovascular disease.

Authors:  Giuseppe Di Pasquale; Stefano Urbinati; Enrica Perugini; Simona Gambetti
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

Review 7.  The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease.

Authors:  Mingming Ning; Eng H Lo; Pei-Chen Ning; Su-Yu Xu; David McMullin; Zareh Demirjian; Ignacio Inglessis; G William Dec; Igor Palacios; Ferdinando S Buonanno
Journal:  Pharmacol Ther       Date:  2013-03-23       Impact factor: 12.310

8.  Patent foramen ovale closure.

Authors:  Zahid Amin
Journal:  Ann Pediatr Cardiol       Date:  2010-01

Review 9.  Pharmaco-proteomics opportunities for individualizing neurovascular treatment.

Authors:  M M Ning; M Lopez; D Sarracino; J Cao; M Karchin; D McMullin; X Wang; F S Buonanno; E H Lo
Journal:  Neurol Res       Date:  2013-06       Impact factor: 2.448
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.